To confirm the significant value of LRIG1 for predicting the prognosis in NSCLC, we have analyzed the correlation between sex, age, pathological type, differentiation status, tumor staging, smoking history and LRIG1 expression levels with OS (Fig. 4), and assessed the prognostic efficacy of LRIG1. This evidence concerns the gene LRIG1 and non-small cell lung carcinoma.